focus -WSS

focus

author：comprehensive 2025-10-02 19:38:47 - browse：4558

Bob Kocher, a partner at venture capital firm Venrock, speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health.

“They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said. “If you’re sad, anxious, or depressed, why bother with people?”

Kocher, who is also a doctor and helped write the Affordable Care Act as an Obama administration health official, shared his thoughts on the biggest questions facing digital health at STAT’s Breakthrough Summit on Thursday. Besides sharing a peek inside his generative AI pitch-filled inbox, Kocher talked about cybersecurity vulnerabilities in health systems and venture capitalists buying hospitals.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout LOUD podcast, live from the STAT Breakthrough Summit East

WSS

Bring on the sabbaticals for nurses

Steward Health Care expansion into Malta flopped

Why health care costs have stayed mostly flat since 2010

Diabetes management: Digital health tools fall short, study says

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Readout Newsletter: Illumina, CRISPR, Regeneron

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Psychedelics group wrestles with new pharma identity

This gene therapy has record $4.25 million price. It's saved children.

After affirmative action ruling, medical educators look to 'holistic review'

Three trends to watch in biotech in 2024

Cancer drug shortages should be causing more outrage

Grail spinoff by Illumina should end disastrous merger attempt

Dobbs anniversary: the lost opportunity of abortion as health care

Cancer, immunology, HIV research ensnared in fetal tissue politics

Guidelines to prevent youth baseball injuries need more muscle

Yancopoulos of Regeneron works to expand Dupixent success

entertainment

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Why health records don't always know when patients are dead

Erich Jarvis studies song birds to learn about human stuttering

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Keeping primary care docs in field isn't impossible, says AAFP CEO

CRISPR technology availability, affordability needs to be expanded

hotspot

hotspot

focus

leisure time